Scarlett L. Gomez
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Breast Cancer in Asian American Women
Open Date: 2024-10-01
Close Date: 2025-09-30
Articles (8)
Background: Research has linked neighborhood factors (e.g., air pollution, obesogenic environment) often associated with residential segregation to cancer disparities, including mortality. Limited research has explored these multilevel drivers of health, recognizing residential segregation as upstream of neighborhood social, built, and physical environment attributes. In this study, we describe the neighborhood data resource of the Pathways Study, a diverse cohort of women diagnosed with breast cancer. Methods: Using data from multiple sources, including the 2010 US Census, we appended census tract and block group-level measures that characterize the participants’ baseline neighborhoods. We examined distributions of neighborhood attributes by the Index of Concentration at the Extremes, a measure of racialized economic segregation, to demonstrate the relationships among these factors. Results: Twenty-eight percent of the participants resided in neighborhoods with the highest concentrations of high-income non-Hispanic White residents [i.e., most privileged neighborhoods; quintile (Q) 5] compared with only 9% who resided in neighborhoods with the highest concentrations of low-income residents from minoritized racial/ethnic groups (i.e., least privileged neighborhoods, Q1). Participants residing in less privileged neighborhoods had more exposure to detrimental neighborhood attributes, including a higher overall pollution burden, markers of physical disorder (e.g., graffiti and garbage), more barred windows, and a higher crime index. Conclusions: For a cohort of breast cancer survivors, residing in neighborhoods with less privilege shows evidence of adverse neighborhood attributes across domains of social, built, and physical environments. Impact: This neighborhood infrastructure is well positioned to assess interactions across the multilevel factors contributing to health disparities in women with breast cancer.
Year:
2026
Supplementary Table S1: Prevalence ratios for the association of nativity (foreign-born vs US-born) with optimal category of healthy lifestyle index (HLI) score by ethnic subcategory in women from the Pathways and CHI Studies (N = 3,399)
Year:
2025
Background: In the United States, breast cancer is common in Asian, Hispanic, and non-Hispanic White (NHW) women, many of whom are immigrants. A healthy lifestyle is vital to survival, but it is unknown how lifestyle varies by nativity among survivors. Methods: The study included 4,754 racially diverse, female breast cancer survivors from the Northern California, Exploring Networks in a Cohort of Latina and Asian Emigrants, Lifestyle, and Vital Status (ENCLAVE) study. We generated a healthy lifestyle index (HLI) based on World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations. Log-binomial regression models, controlling for sociodemographics, were used to evaluate associations between nativity and the highest tertile of HLI, as well as the optimal category of each HLI component. Results: Foreign-born (vs. US-born) women were more likely to have a high HLI [prevalence ratio (PR) = 1.44; 95% confidence interval (CI), 1.31–1.59]. In stratified models, we observed stronger associations among Hispanic (PR = 1.76; 95% CI, 1.39–2.24) and Asian (PR = 1.60; 95% CI, 1.32–1.94) versus non-Hispanic White (PR = 1.26; 95% CI, 1.08–1.47) women ( P -interaction = 0.02). Foreign-born (vs. US-born) women were more likely to have a waist circumference Conclusions: Among women diagnosed with breast cancer, foreign-born women had a healthier lifestyle than US-born women. Impact: Lifestyle differences by nativity in breast cancer survivors may help clarify prognostic differences by nativity.
Year:
2025
Background: In the United States, breast cancer is common in Asian, Hispanic, and non-Hispanic White (NHW) women, many of whom are immigrants. A healthy lifestyle is vital to survival, but it is unknown how lifestyle varies by nativity among survivors. Methods: The study included 4,754 racially diverse, female breast cancer survivors from the Northern California, Exploring Networks in a Cohort of Latina and Asian Emigrants, Lifestyle, and Vital Status (ENCLAVE) study. We generated a healthy lifestyle index (HLI) based on World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations. Log-binomial regression models, controlling for sociodemographics, were used to evaluate associations between nativity and the highest tertile of HLI, as well as the optimal category of each HLI component. Results: Foreign-born (vs. US-born) women were more likely to have a high HLI [prevalence ratio (PR) = 1.44; 95% confidence interval (CI), 1.31–1.59]. In stratified models, we observed stronger associations among Hispanic (PR = 1.76; 95% CI, 1.39–2.24) and Asian (PR = 1.60; 95% CI, 1.32–1.94) versus non-Hispanic White (PR = 1.26; 95% CI, 1.08–1.47) women (P-interaction = 0.02). Foreign-born (vs. US-born) women were more likely to have a waist circumference <31.5 inches (PR = 1.19; 95% CI, 1.03–1.37); be normal weight (PR = 1.23; 95% CI, 1.11–1.37); never smoke (PR = 1.11; 95% CI, 1.06–1.17); and consume no sweets (PR = 1.44; 95% CI, 1.21–1.70), low red meat (PR = 1.46; 95% CI, 1.33–1.60), and high fruits and vegetables (PR = 1.46; 95% CI, 1.32–1.62). Conclusions: Among women diagnosed with breast cancer, foreign-born women had a healthier lifestyle than US-born women. Impact: Lifestyle differences by nativity in breast cancer survivors may help clarify prognostic differences by nativity.
Year:
2025
Background: The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations. Methods: The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors. Results: The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis. Conclusions: The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021). Impact: Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
Year:
2025
Background: Cancer rates in rural areas vary by insurance status, socioeconomic status, region, race, and ethnicity. Methods: California Cancer Registry data (2015–2019) were used to investigate the stage of diagnosis by levels of rurality for the five most common cancers. The percentage of residents in rural blocks within census tract aggregation zones was categorized into deciles up to 50%. Multivariable logistic regression was used to estimate associations with rurality, with separate models by cancer site, sex, race, and ethnicity (non-Hispanic White and Hispanic). Covariates included individual-level and zone-level factors. Results: The percentage of late-stage cancer diagnosis was 28% for female breast, 27% for male prostate, 77% for male lung, 71% for female lung, 60% for male colorectal, 59% for female colorectal, 7.8% for male melanoma, and 5.9% for female melanoma. Increasing rurality was significantly associated with increased odds of late-stage cancer diagnosis for female breast cancer ( P trend P trend P trend P trend = 0.01), after adjusting for individual-level and zone-level factors. The strength of associations varied by sex and ethnicity. For males with lung cancer, odds of late-stage diagnosis in areas with >50% rural population was 1.24 (95% confidence interval, 1.06–1.45) for non-Hispanic White patients and 2.14 (95% confidence interval, 0.86–5.31) for Hispanic patients, compared with areas with 0% rural residents. Conclusions: Increasing rurality was associated with increased odds for late-stage diagnosis for breast cancer, lung cancer, and melanoma, with the strength of associations varying across sex and ethnicity. Impact: Our findings will inform cancer outreach to these rural subpopulations.
Year:
2024
Background: The COVID-19 pandemic and associated shutdowns disrupted healthcare access and resulted in decreased cancer screenings. Cancer diagnosis delays have concerning downstream effects on late-stage cancer, especially for marginalized populations. Methods: The study population included 349,458 adults in the California Cancer Registry diagnosed with cancer between January 2019 and December 2021, during which California experienced two stay-at-home orders. We examined the percentage of late-stage (III–IV) cancer diagnoses across five periods: Pre-pandemic (January 2019–February 2020), Shutdown #1 (March–June 2020), Post-shutdown #1 (July–November 2020), Post-shutdown #2 (December 2020–March 2021), and Post-vaccine rollout (April–December 2021). To examine the association between time period and late-stage diagnoses, we conducted a multivariable log-binomial regression model adjusted for sociodemographic and neighborhood factors. Results: The percentage of late-stage cancer diagnoses increased during Shutdown #1 (+5.2%) and returned to baseline Post-vaccine rollout. Groups with notably higher increases in the percentage of late-stage cancer (vs. overall population) during Shutdown #1 include Pacific Islander (+13.7%), Thai (+11.2%), Chinese (+8.1%), Native Hawaiian (+7.4%), Filipino (+6.6%), and uninsured (+7.4%). Uninsured [vs. private insurance; prevalence ratio (PR), 1.41], low neighborhood socioeconomic status (nSES; vs. high; PR, 1.19), and racial and ethnic minoritized groups (vs. non-Hispanic White; PR, 1.04–1.19) had higher likelihood for late-stage cancer diagnosis. Conclusions: The pandemic exacerbated late-stage cancer disparities for racial and ethnic minoritized groups, underinsured, and low nSES communities in California (2020–2021). Impact: Interventions to improve cancer screening must be focused on racial and ethnic minoritized, underinsured, and low nSES communities, as they are likely to be more vulnerable to healthcare disruptions like the pandemic.
Year:
2024
Understanding the social and environmental causes of cancer in the United States, particularly in marginalized communities, is a major research priority. Population-based cancer registries are essential for advancing this research, given their nearly complete capture of incident cases within their catchment areas. Most registries limit the release of address-level geocodes linked to cancer outcomes to comply with state health departmental regulations. These policies ensure patient privacy, uphold data confidentiality, and enhance trust in research. However, these restrictions also limit the conduct of high-quality epidemiologic studies on social and environmental factors that may contribute to cancer burden. Geomasking refers to computational algorithms that distort locational data to attain a balance between effectively “masking” the original address location while faithfully maintaining the spatial structure in the data. We propose that the systematic deployment of scalable geomasking algorithms could accelerate research on social and environmental contributions across the cancer continuum by reducing measurement error bias while also protecting privacy. We encourage multidisciplinary teams of registry officials, geospatial analysts, cancer researchers, and others engaged in this form of research to evaluate and apply geomasking procedures based on feasibility of implementation, accuracy, and privacy protection to accelerate population-based research on social and environmental causes of cancer.
Year:
2023
Collaborators (10)
Brittany N. Morey
Associate Professor
University of California
Pushkar Inamdar
University of California, San Francisco
Christine Ambrosone
Roswell Park Comprehensive Cancer Center
Xun Shi
Professor
Dartmouth College
Iona Cheng
University of California
Peggy Reynolds
Professor
University of California, San Francisco
Julie Von Behren
University of California, San Francisco
Niharika Dixit
Professor of Medicine
University of California, San Francisco
Brenda Y Hernandez
University of Hawaii
Salma Shariff‐Marco
Professor
University of California, San Francisco
Make your next move.
Prepare your application
Review drafts before you send them.